APJ as Promising Therapeutic Target of Peptide Analogues in Myocardial Infarction- and Hypertension-Induced Heart Failure.

Rossin D, Vanni R, Lo Iacono M, Cristallini C, Giachino C, Rastaldo R

Open source

DOI
10.3390/pharmaceutics15051408
Published
2023 May 4
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics15051408,
  title = {APJ as Promising Therapeutic Target of Peptide Analogues in Myocardial Infarction- and Hypertension-Induced Heart Failure.},
  author = {Rossin D and Vanni R and Lo Iacono M and Cristallini C and Giachino C and Rastaldo R},
  year = {2023},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics15051408},
  url = {https://doi.org/10.3390/pharmaceutics15051408}
}

RIS

TY  - JOUR
TI  - APJ as Promising Therapeutic Target of Peptide Analogues in Myocardial Infarction- and Hypertension-Induced Heart Failure.
AU  - Rossin D
AU  - Vanni R
AU  - Lo Iacono M
AU  - Cristallini C
AU  - Giachino C
AU  - Rastaldo R
PY  - 2023
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics15051408
UR  - https://doi.org/10.3390/pharmaceutics15051408
ER  - 

APA

D, R., R, V., M, L. I., C, C., C, G., & R, R. (2023). APJ as Promising Therapeutic Target of Peptide Analogues in Myocardial Infarction- and Hypertension-Induced Heart Failure.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics15051408

Source records